Drug Discovery
238 articles · 8 journals
Journals in this subcategory (8)
- Molecular Therapy: Nucleic Acids · Elsevier (80)
- Molecular Therapy · Elsevier (79)
- Phytomedicine · Elsevier (79)
- Archives of Pharmacal Research · Springer Nature (0)
- EPMA Journal · Springer Nature (0)
- Human Genomics · Springer Nature (0)
- Journal of Natural Medicines · Springer Nature (0)
- Pharmaceutical Chemistry Journal · Springer Nature (0)
- Betulonic acid, a bioactive triterpenoid from Celastrus orbiculatus extract, reverses chemoresistance in gastric cancer via CD44v6-mediated actin cytoskeleton remodeling
- Artesunate reverses alveolar macrophage immunometabolic collapse and prevents breast cancer lung metastasis via the SREBP1- and FATP4-dependent fatty acid axis
- The edible dietary fiber of Lentinus β-glucan targets PRSS3 to suppress progression of human colon cancer
- Zuojin Wan reverses cetuximab resistance in KRAS-mutant colorectal cancer via the NRF2-GCH1/CoQ and DHODH/CoQ axes
- Molecular engineering of zinc finger nucleases significantly enhances genome editing efficiency in cells
- A helicase-fused Cas9 improves large-size fragment knockin
- Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression
- Lipid nanoparticles advance doggybone DNA vaccination in non-human primates
- DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
- Beyond CD19: Pairing broader antigen recognition with strategies to counter CAR-T cell exhaustion
- A single-dose combinatorial gene therapy with AAV based FGF21 and SIRT1 impacts aging-associated metabolic and mitochondrial function
- Cas9 Immunogenicity and Translational Implications for CRISPR-Cas9 Mediated Gene Therapy Interventions
- Aptamers in neurodegenerative disease: Systematic review and computational analysis of aptamer-protein interactions
- RNA modifications in cancer therapy resistance: Mechanisms and therapeutic targeting
- Imperatorin exerts anti-colorectal cancer effects by targeting NOX2 to inhibit mast cell degranulation
- Modulating pMMR colorectal tumors toward a dMMR-like phenotype by Xian-Lian-Jie-Du decoction enhances anti-PD-1 efficacy
- Natural products as modulators of Hippo signaling: mechanisms, pharmacology and translational challenges
- Shenlingcao oral liquid suppresses colorectal cancer by reprogramming the immune microenvironment and inhibiting pro-tumorigenic inflammation
- Periplogenin rewires cholesterol-dependent signaling and antitumor immunity by targeting PCSK9 in cholangiocarcinoma
- From self-amplification to engineered replication: Designing next-generation saRNA platforms
- A modular AU-rich stem-loop in the 3′ UTR enhances protein expression through L1RE1
- A single-nucleotide change in the Kozak sequence enhances protein expression from IVT mRNA
- Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation
- CochleaNet: Deep learning-based image analysis for cochlear connectomics and gene therapy
- The Circular RNA circSKA3 Binds Integrin β1 to Induce Invadopodium Formation Enhancing Breast Cancer Invasion
- Sharpening therapeutic tools toward blunting pathological nuclear lamina with advanced in vitro disease modeling
- Hyaluronan accumulation mediated by Human Identical Sequences provides a broad-spectrum therapeutic strategy against virulent coronaviruses
- Absence of Hepatobiliary Toxicity in Large Animal Species Dosed with AAV8 Gene Therapy for X-linked Myotubular Myopathy
- Nucleic Acid Therapeutics for Treating Glioblastoma: From Modality and Delivery Design to Scalable Nanomedicine Platforms
- Artemisitene targets GLIS3 to inhibit the NF-κB-TNF signaling pathway and suppress bladder cancer cell growth